BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37860371)

  • 1. Retracted: Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9834327. PubMed ID: 37860371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
    Xu X; Lu F; Fang C; Liu S
    J Healthc Eng; 2022; 2022():7832618. PubMed ID: 35242299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Verification of Immune-Related Genes Prognostic Signature Based on ssGSEA for Adrenocortical Carcinoma (ACC).
    Yuan K; Zeng R; Deng P; Zhang A; Liu H; Wang N; Tang Y; Yin Z; Liu H
    Int J Gen Med; 2022; 15():1471-1483. PubMed ID: 35210821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma.
    Zhou X; Zhang H; Duan Y; Zhu J; Dai H
    J Clin Lab Anal; 2023 Jan; 37(1):e24813. PubMed ID: 36525280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value and Immune-Infiltration Pattern of
    Yang Z; Shen X; Luo S; Li Y
    Dis Markers; 2022; 2022():9621701. PubMed ID: 35126794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas.
    Li X; Huang Z; Zhu L; Yu F; Feng M; Gu A; Jiang J; Wang G; Huang D
    Front Genet; 2022; 13():905751. PubMed ID: 35923699
    [No Abstract]   [Full Text] [Related]  

  • 9. Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9893576. PubMed ID: 37387801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of autophagy-related long non-coding RNAs in endometrial cancer via comprehensive bioinformatics analysis.
    Liu H; Cheng Y
    BMC Womens Health; 2022 Mar; 22(1):85. PubMed ID: 35321716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9753718. PubMed ID: 37799422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of an autophagy-related gene expression signature for endometrial cancer patients.
    Wang H; Ma X; Liu J; Wan Y; Jiang Y; Xia Y; Cheng W
    Cancer Cell Int; 2020; 20():306. PubMed ID: 32684843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
    Li N; Yu K; Lin Z; Zeng D
    Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
    Zhao T; Zhang Y; Ma X; Wei L; Hou Y; Sun R; Jiang J
    Cancer Cell Int; 2021 May; 21(1):269. PubMed ID: 34016103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9850950. PubMed ID: 37387830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Analysis of the Glycolysis-Related Gene Prognostic Signature and Immune Infiltration in Endometrial Cancer.
    Yang X; Li X; Cheng Y; Zhou J; Shen B; Zhao L; Wang J
    Front Cell Dev Biol; 2021; 9():797826. PubMed ID: 35223866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma.
    Chen X; Zhang W; Zhu H; Lin F
    Med Sci Monit; 2021 Feb; 27():e928949. PubMed ID: 33577492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification of
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9876978. PubMed ID: 37564808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.